ω-hydroxylation of phytanic acid in rat liver microsomes: Implications for Refsum disease

Journal of Lipid Research

Volumn 45, Issue 7, 2004, Pages 1341-1346

  Komen, J C ^a   Duran, M ^a   Wanders, R J A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

oxidation; Cytochrorne P450; Fatty acids

Indexed keywords

CYTOCHROME P450; IMIDAZOLE DERIVATIVE; OMEGA 1 HYDROXYPHYTANIC ACID; OMEGA HYDROXYPHYTANIC ACID; OXYGENASE; PHYTANIC ACID; PHYTANOYL COENZYME A HYDROXYLASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; FATTY ACID OXIDATION; GENE MUTATION; HUMAN; HYDROXYLATION; LIPID DEGRADATION; LIVER MICROSOME; METABOLITE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; REFSUM DISEASE;

ANIMALS; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; HYDROXYLATION; MALE; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; NADP; PHYTANIC ACID; PROTEIN ISOFORMS; RATS; RATS, WISTAR; REFSUM DISEASE;

EID: 3042520951     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400064-JLR200     Document Type: Article

References (24)

1. Wanders, R. J., P. Vreken, S. Ferdinandusse, G. A. Jansen, H. R. Waterham, C. W. van Roermund, and E. G. Van Grunsven. 2001. Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem. Soc. Trans. 29: 250-267.
2. Wanders, R. J., C. Jakobs, and O. H. Skjeldal. 2001. Refsum disease. In The Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver, A. L. Beaudet, D. Valle, and W. S. Sly, editors. McGraw-Hill, New York. 3303-3322.
3. Mukherji, M., C. J. Schofield, A. S. Wierzbicki, G. A. Jansen, R. J. Wanders, and M. D. Lloyd. 2003. The chemical biology of branched-chain lipid metabolism. Prog. Lipid Res. 42: 359-376.
4. Wierzbicki, A. S., M. D. Lloyd, C. J. Schofield, M. D. Feher, and F. B. Gibberd. 2002. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. J. Neurochem. 80: 727-735.
5. Jansen, G. A., R. Ofman, S. Ferdinandusse, L. Ijlst, A. O. Muijsers, O. H. Skjeldal, O. Stokke, C. Jakobs, G. T. Besley, J. E. Wraith, and R.J. Wanders. 1997. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat. Genet. 17: 190-193.
6. Jansen, G. A., R. J. Wanders, P. A. Watkins, and S. J. Mihalik. 1997. Phytanoyl-coenzyme A hydroxylase deficiency - the enzyme defect in Refsum's disease. N. Engl. J. Med. 337: 133-134.
7. Mihalik, S. J., J. C. Morrell, D. Kim, K. A. Sacksteder, P. A. Watkins, and S. J. Gould. 1997. Identification of PAHX, a Refsum disease gene. Nat. Genet. 17: 185-189.
8. Okita, R. T., and J. R. Okita. 2001. Cytochrome P450 4A fatty acid omega hydroxylases. Curr. Drug Metab. 2: 265-281.
9. Simpson, A. E. 1997. The cytochrome P450 4 (CYP4) family. Gen. Pharmacol. 28: 351-359.
10. Try, K. 1968. The in vitro omega-oxidation of phytanic acid and other branched chain fatty acids by mammalian liver. Scand. J. Clin. Lab. Invest. 22: 224-230.
11. Billimoria, J. D., M. E. Clemens, F. B. Gibberd, and M. N. Whitelaw. 1982. Metabolism of phytanic acid in Refsum's disease. Lancet. 1: 194-196.
12. Brenton, D. P., and S. Krywawych. 1982. 3-Methyladipate excretion in Refsum's disease. Lancet. 319: 624.
13. Greter, J., S. Lindstedt, and G. Steen. 1983. 2,6-Dimethyloctanedioic acid-a metabolite of phytanic acid in Refsum's disease. Clin. Chem. 29: 434-437.
14. Wierzbicki, A. S., P. D. Mayne, M. D. Lloyd, D. Burston, G. Mei, M. C. Sidey, M. D. Feher, and F. B. Gibberd. 2003. Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease. J. Lipid Res. 44: 1481-1488.
15. Baudhuin, P., H. Beaufay, Y. Rahman-Li, O. Z. Sellinger, R. Wattiaux, P. Jacques, and C. De Duve. 1964. Tissue fractionation studies. 17. Intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, D-amino acid oxidase and catalase in rat-liver tissue. Biochem. J. 92: 179-184.
16. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
17. Chalmers, R. A., and A. M. Lawson. 1982. Organic Acids in Man: The Analytical Chemistry, Biochemistry and Diagnosis of the Organic Acidurias. Chapman and Hall, London.
18. Jakobs, C., M. Bojasch, E. Monch, D. Rating, H. Siemes, and F. Hanefeld. 1981. Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism. Clin. Chim. Acta. 111: 169-178.
19. Mamer, O. A., J. A. Montgomery, and E. Colle. 1980. Profiles in altered metabolism. II. (Omega-1)-hydroxyacid excretion in a case of episodic hypoglycemia. Biomed. Mass Spectrom. 7: 53-57.
20. Muralidharan, V. B., and Y. Kishimoto. 1984. Phytanic acid alpha-oxidation in rat liver. Requirement of cytosolic factor. J. Biol. Chem. 259: 13021-13026.
21. Singh, I., and Y. Kishimoto. 1983. Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside, and on the enzymatic reactions involving these compounds. J. Lipid Res. 24: 662-665.
22. Halpert, J. R. 1995. Structural basis of selective cytochrome P450 inhibition. Annu. Rev. Pharmacol. Toxicol. 35: 29-53.
23. Zhang, W., Y. Ramamoorthy, T. Kilicarslan, H. Nolte, R. F. Tyndale, and E. M. Sellers. 2002. Inhibition of cytochromes P450 by anti-fungal imidazole derivatives. Drug Metab. Dispos. 30: 314-318.
24. Maurice, M., L. Pichard, M. Daujat, I. Fabre, H. Joyeux, J. Domergue, and P. Maurel. 1992. Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J. 6: 752-758.